Skip to main content

The Science of Psychedelics

Tuesday, July 7, 2020
7:30 pm
KQED Broadcast: 07/12/2020, 07/14/2020, 07/15/2020

This event appeared in the series
Conversations on Science

Watch the webcast on YouTube now →

We’ve made our content free to all. Please support our institution and these productions by making a tax-deductible contribution.

Can LSD and psilocybin provide relief to people suffering from difficult-to-treat conditions such as depression and anxiety? Robin Carhart-Harris is a neuroscientist and head of the Imperial Centre for Psychedelic Research, which builds on over a decade of pioneering work psychedelic research, including a clinical trial that has kick-started global efforts to develop psilocybin therapy into a licensed treatment for depression. The Centre focuses on two main research themes: the use of psychedelics in mental health care; and as tools to probe the brain’s basis of consciousness. The Centre is also working to develop a research clinic that could help to gather additional clinical evidence and become a prototype for the licensed psychedelic care facilities of the future.

Mellody Hayes, MD is the Founder and CEO of Ceremony Health, a psychedelic wellness clinic in Berkeley.  A Harvard College graduate and UCSF-trained anesthesiologist, she is a writer, public speaker, and spiritual coach.